OnabotulinumToxinA Reduces Pharmacological Burden in Chronic Migraine Patients: A Two-Center Prospective Cohort Study. [PDF]
Montisano DA +9 more
europepmc +1 more source
This graphical abstract illustrates the conceptual pathway investigated in this cross‐sectional study: stress experienced by adolescents may be associated with self‐reported bruxism (sleep and awake), which in turn shows a significant association with primary headache (tension‐type or migraine). The findings indicate significant associations among self‐
Amanda Carolina Flor Soares +3 more
wiley +1 more source
Comparing Phase III Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) and Targeted Approaches for OnabotulinumtoxinA in Chronic Migraine Treatment. [PDF]
Nag S, Kennedy P, Weber KD, Janis JE.
europepmc +1 more source
The use of OC has been demonstrated to enhance the likelihood of encountering self‐reported headaches and increased tenderness to palpation within the masticatory system in female adolescents. ABSTRACT Background The utilisation of oral contraceptives (OCs) has been demonstrated to be associated with the self‐reported occurrence of headaches in female ...
Henriette I. U. Stasche +6 more
wiley +1 more source
Effects of vagal nerve stimulation on pain frequency and intensity in chronic migraine in adults: A randomized controlled trial. [PDF]
Nasir R +6 more
europepmc +1 more source
Periventricular diffusivity at the ventricular-parenchymal interface across healthy controls, episodic migraine, and chronic migraine: a cross-sectional multimodal MRI study. [PDF]
Fu F +16 more
europepmc +1 more source
Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. [PDF]
Qaqish A, Al Anber A, Abdelhafez G.
europepmc +1 more source
Re-assessing the clinical significance of long-term neuromuscular alterations following Onabotulinumtoxin-A (BoNTA) in chronic migraine: Letter to the editor on behalf of the GRASP study group. [PDF]
Argyriou AA +5 more
europepmc +1 more source
Efficacy of Erenumab in Patients With Treatment-Resistant Chronic Migraine and Medication Overuse Headache. [PDF]
Binfalah MF +3 more
europepmc +1 more source

